Andrew Welch

Andrew Welch , DO

Assistant Professor of Clinical

Medical Sciences Building

COM IM Endocrinology Division - 0547


BS: Brigham Young University Provo, UT, 2013 (Neuroscience)

DO: Arizona College of Osteopathic Medicine Glendale, AZ, 2020


American Board of Internal Medicine (Certification Date: 08-20-2020 )

American Board of Internal Medicine (Endocrinology-Diabetes and Metabolism) (Certification Date: 10-24-2023 )

Clinical Interests


Diabetes Mellitus

Diabetes Type 1 (Diabetes Mellitus, Type 1)

Diabetes Type 2 (Diabetes Mellitus, Type 2)

Diabetic Foot

Diabetic Hypoglycemia

Diabetic Ketoacidosis

Diabetic Nephropathy

Diabetic Neuropathies

Thyroid Cancer

Adrenal Insufficiency

Adrenocortical Adenoma

Cushing syndrome (Hypercortisolism)



Hypothyroidism (Underactive thyroid)



Pituitary Adenoma



Endocrinology-Diabetes and Metabolism

Internal Medicine


Peer Reviewed Publications

Welch, Andrew A; Farahani, Rahele A; Egan, Aoife M; Laurenti, Marcello C; Zeini, Maya; Vella, Max; Bailey, Kent R; Cobelli, Claudio; Dalla Man, Chiara Dalla; Matveyenko, Aleksey; Vella, Adrian (2023. ) The effect of Glucagon-Like Peptide-1 Receptor blockade on islet secretion and glucose metabolism in humans.The Journal of clinical investigation, , More Information

Schembri Wismayer, Daniel; Laurenti, Marcello C; Song, Yilin; Egan, Aoife M; Welch, Andrew A; Bailey, Kent R; Cobelli, Claudio; Dalla Man, Chiara; Jensen, Michael D; Vella, Adrian (2023. ) Effects of acute changes in fasting glucose and free fatty acid concentrations on indices of β-cell function and glucose metabolism in subjects without diabetes.American journal of physiology. Endocrinology and metabolism, , 325 (2 ) ,E119-E131 More Information

Farahani, Rahele A; Egan, Aoife M; Welch, Andrew A; Laurenti, Marcello C; Cobelli, Claudio; Dalla Man, Chiara; Vella, Adrian (2023. ) The Effect of Glucagon-Like Peptide 1 Receptor Blockade on Glucagon-Induced Stimulation of Insulin Secretion.Diabetes, , 72 (4 ) ,449-454 More Information

Brar, Gurkirat S; Barrow, Breanne M; Watson, Matthew; Griesbach, Ryan; Choung, Edwina; Welch, Andrew; Ruzsicska, Bela; Raleigh, Daniel P; Zraika, Sakeneh (2017. ) Neprilysin Is Required for Angiotensin-(1-7)'s Ability to Enhance Insulin Secretion via Its Proteolytic Activity to Generate Angiotensin-(1-2).Diabetes, , 66 (8 ) ,2201-2212 More Information